The Saroja Pharma IPO started on August 31, 2023, and ended on September 5, 2023. Shares were allocated on September 8, 2023, and refund processes began on September 11, 2023. On September 12, 2023, the shares were credited to investors demat accounts. Saroja Pharma was officially listed on the stock exchange on September 13, 2023.
During the IPO, Saroja Pharma offered shares at a price range of ₹84 per share, and the lot size was 1600 shares. The total issue size was ₹9.11 crores, with ₹9.11 crores from new shares. The IPO was listed on the NSE SME.
Regarding share reservations, 50% of the shares were allocated to other and 50% were set aside for retail investors.
Saroja Pharma Industries IPO Subscription Update Video
Saroja Pharma IPO Subscription Status
The Saroja Pharma IPO on September 5, 2023 was subscribed 8.88 times, with the retail category being subscribed 14.83 times, the other category being subscribed 2.90 times.
| Category | Subscription |
| Other | 2.90x |
| Retail | 14.83x |
| Total | 8.88x |
Saroja Pharma Industries India Limited IPO Basic Details
| Company Name | Saroja Pharma Industries India Limited |
| Domain of Company | Trade, export, and supply of Specialty Chemicals and Active Pharmaceutical Ingredients (APIs) |
| IPO Open Date | August 31, 2023 |
| IPO Close Date | September 5, 2023 |
| IPO Allotment Date | September 8, 2023 |
| IPO Listing Date | September 13, 2023 |
| Face Value | ₹10 per share |
| Price | ₹84 per share |
| Lot Size | 1600 Shares |
| Issue Size | 1,084,800 shares of ₹10 (aggregating up to ₹9.11 Cr) |
| Fresh Issue | 1,084,800 shares of ₹10 (aggregating up to ₹9.11 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Company Promoters | Mr. Biju Gopinathan Nair And Mr. Manish Dasharath Kamble |
About Saroja Pharma Industries India Limited
Established in 2019, Saroja Pharma Industries India Limited operates in the trade, export, and supply of Specialty Chemicals & API. The company is involved in three primary product categories: Chemicals, Pharma Intermediaries, and Veterinary Pharma API. Its product line includes items like Liquid Bromine utilized as an agro-intermediate, Ethyl Acetate serving as an API solvent, along with various pharmaceuticals designed for both human and veterinary applications, some of which also function as API solvents.
APIs, referred to as bulk drugs or bulk actives, form the core components used in creating finalized dosages, including capsules, tablets, liquids, and other forms, by incorporating additional APIs or inactive ingredients.
Saroja Pharma Industries India Limited predominantly exports its products to countries like Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.
Notable Competitive Advantages:
- A seasoned team of promoters and management professionals
- A scalable and adaptable business model
- A comprehensive and diversified array of product offerings
- Varied business operations contributing to a broad revenue base
Saroja Pharma Industries IPO Should you subscribe?
Saroja Pharma Industries India IPO More Details Click Here
Saroja Pharma IPO FAQs
What is the start and end date of Saroja Pharma IPO Subscription?
The Saroja Pharma IPO started on August 31, 2023, and ended on September 5, 2023.
When does Saroja Pharma IPO Subscription open?
The Saroja Pharma IPO open on August 31, 2023.
When does Saroja Pharma IPO Subscription close?
The Saroja Pharma IPO Close on September 5, 2023.
What is the allotment date of Saroja Pharma IPO?
The allotment date for Saroja Pharma IPO is September 8, 2023.
When is the initial refund date of Saroja Pharma IPO?
The initial Refund date for Saroja Pharma IPO is September 11, 2023.
When were the shares credited to investors demat accounts for the Saroja Pharma IPO?
The shares for the Saroja Pharma IPO were credited to investors demat accounts on September 12, 2023.
When will Saroja Pharma IPO be listed on the stock market?
Saroja Pharma IPO stock market will be listed on September 13, 2023 at 10 am.
What was the price range of the Saroja Pharma IPO shares?
The Saroja Pharma IPO shares were offered at a price range of ₹84 per share.
What was the lot size for the Saroja Pharma IPO shares?
The lot size for the Saroja Pharma IPO shares was 1600 shares.
What was the total issue size of the Saroja Pharma IPO?
The total issue size of the Saroja Pharma IPO was ₹9.11 crores.
How were the shares allocated among different types of investors for the Saroja Pharma IPO?
50% of the shares were allocated to other and 50% were set aside for retail investors.
On which stock exchanges was the Saroja Pharma IPO listed?
The Saroja Pharma IPO was listed on the NSE SME.
What is the Saroja Pharma IPO Subscription Status?
Saroja Pharma IPO is subscribed 2.09 Times.
